InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+8.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Chattopadhyay Sanat, Vice-président exécutif et président. Officer active across 1 company, notably Merck & Co., Inc.. Aggregated, 10 disclosures have been logged. Activity tracked since 29 October 2021. The latest transaction was disclosed on 29 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations10 total
1,130 shares@ US$110.030.0000% mcap0.6% of flowCommon StockSEC:0000310158-26-000097:1
2,597 shares@ US$110.030.0001% mcap1.5% of flowCommon StockSEC:0000310158-26-000097:0
28,136 shares@ US$97.9416.2% of flowCommon StockSEC:0001127602-25-002336:0
26,716 shares@ US$119.4318.0% of flowCommon StockSEC:0001127602-24-002015:0
67,892 shares@ US$56.0421.2% of flowCommon StockSEC:0001127602-23-012932:0
17,495 shares@ US$109.8810.9% of flowCommon StockSEC:0001127602-23-002193:0
83,994 shares@ US$53.0625.7% of flowCommon StockSEC:0001127602-23-001274:0
15,213 shares0Common StockSEC:0001127602-22-024629:0
19,836 shares@ US$73.510.0005% mcap100.0% of flowCommon StockSEC:0001127602-22-007000:0
24,619 shares0Common StockSEC:0001127602-21-028167:0
10 of 10 declarations
About Chattopadhyay Sanat
Sanat Chattopadhyay is the Executive Vice President and President of MMD at Merck & Co., Inc. In this role, he oversees the company's operations and leads strategic initiatives. Sanat brings significant expertise in the pharmaceutical sector, contributing to innovation and process efficiency within Merck.
